AVXL
Price
$9.22
Change
-$0.23 (-2.43%)
Updated
Aug 28 closing price
Capitalization
791.94M
115 days until earnings call
CRVO
Price
$9.32
Change
-$0.07 (-0.75%)
Updated
Aug 28 closing price
Capitalization
81.11M
Interact to see
Advertisement

AVXL vs CRVO

Header iconAVXL vs CRVO Comparison
Open Charts AVXL vs CRVOBanner chart's image
Anavex Life Sciences
Price$9.22
Change-$0.23 (-2.43%)
Volume$780.49K
Capitalization791.94M
CervoMed
Price$9.32
Change-$0.07 (-0.75%)
Volume$28.68K
Capitalization81.11M
AVXL vs CRVO Comparison Chart in %
Loading...
AVXL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AVXL vs. CRVO commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVXL is a Buy and CRVO is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (AVXL: $9.22 vs. CRVO: $9.32)
Brand notoriety: AVXL and CRVO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVXL: 74% vs. CRVO: 7%
Market capitalization -- AVXL: $791.94M vs. CRVO: $81.11M
AVXL [@Biotechnology] is valued at $791.94M. CRVO’s [@Biotechnology] market capitalization is $81.11M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.52B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVXL’s FA Score shows that 0 FA rating(s) are green whileCRVO’s FA Score has 0 green FA rating(s).

  • AVXL’s FA Score: 0 green, 5 red.
  • CRVO’s FA Score: 0 green, 5 red.
According to our system of comparison, CRVO is a better buy in the long-term than AVXL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVXL’s TA Score shows that 4 TA indicator(s) are bullish while CRVO’s TA Score has 3 bullish TA indicator(s).

  • AVXL’s TA Score: 4 bullish, 6 bearish.
  • CRVO’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, both AVXL and CRVO are a bad buy in the short-term.

Price Growth

AVXL (@Biotechnology) experienced а -3.46% price change this week, while CRVO (@Biotechnology) price change was +1.08% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.11%. For the same industry, the average monthly price growth was +20.33%, and the average quarterly price growth was +29.99%.

Reported Earning Dates

AVXL is expected to report earnings on Dec 22, 2025.

Industries' Descriptions

@Biotechnology (+2.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AVXL($792M) has a higher market cap than CRVO($81.1M). CRVO YTD gains are higher at: 298.291 vs. AVXL (-14.153). CRVO has higher annual earnings (EBITDA): -24.56M vs. AVXL (-45.88M). AVXL has more cash in the bank: 101M vs. CRVO (33.5M). CRVO has less debt than AVXL: CRVO (0) vs AVXL (88.2K). AVXL (0) and CRVO (0) have equivalent revenues.
AVXLCRVOAVXL / CRVO
Capitalization792M81.1M977%
EBITDA-45.88M-24.56M187%
Gain YTD-14.153298.291-5%
P/E RatioN/A4.73-
Revenue00-
Total Cash101M33.5M301%
Total Debt88.2K0-
FUNDAMENTALS RATINGS
AVXL vs CRVO: Fundamental Ratings
AVXL
CRVO
OUTLOOK RATING
1..100
5370
VALUATION
overvalued / fair valued / undervalued
1..100
57
Fair valued
40
Fair valued
PROFIT vs RISK RATING
1..100
83100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
4936
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
90n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CRVO's Valuation (40) in the Biotechnology industry is in the same range as AVXL (57). This means that CRVO’s stock grew similarly to AVXL’s over the last 12 months.

AVXL's Profit vs Risk Rating (83) in the Biotechnology industry is in the same range as CRVO (100). This means that AVXL’s stock grew similarly to CRVO’s over the last 12 months.

AVXL's SMR Rating (100) in the Biotechnology industry is in the same range as CRVO (100). This means that AVXL’s stock grew similarly to CRVO’s over the last 12 months.

CRVO's Price Growth Rating (36) in the Biotechnology industry is in the same range as AVXL (49). This means that CRVO’s stock grew similarly to AVXL’s over the last 12 months.

CRVO's P/E Growth Rating (100) in the Biotechnology industry is in the same range as AVXL (100). This means that CRVO’s stock grew similarly to AVXL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AVXLCRVO
RSI
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
88%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
84%
Momentum
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
76%
Bearish Trend 1 day ago
85%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
83%
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
82%
Advances
ODDS (%)
Bullish Trend 23 days ago
79%
Bullish Trend 4 days ago
83%
Declines
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
80%
Bullish Trend 1 day ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
AVXL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CNREX23.87N/A
N/A
Commonwealth Real Estate Securities
HSMVX13.72N/A
N/A
Hartford Small Cap Value R6
MRGBX44.98N/A
N/A
MFS Core Equity B
MRBPX23.84N/A
N/A
BlackRock Balanced R
ABEYX20.15N/A
N/A
American Beacon International Eq Y

AVXL and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVXL has been loosely correlated with PLRX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if AVXL jumps, then PLRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVXL
1D Price
Change %
AVXL100%
-2.43%
PLRX - AVXL
48%
Loosely correlated
-4.14%
TENX - AVXL
47%
Loosely correlated
+0.17%
AXON - AVXL
45%
Loosely correlated
+1.59%
RXRX - AVXL
42%
Loosely correlated
-0.51%
VCYT - AVXL
41%
Loosely correlated
+4.68%
More

CRVO and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRVO has been loosely correlated with TCRX. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if CRVO jumps, then TCRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRVO
1D Price
Change %
CRVO100%
-0.75%
TCRX - CRVO
34%
Loosely correlated
-2.67%
LVTX - CRVO
31%
Poorly correlated
N/A
NKTR - CRVO
27%
Poorly correlated
+0.20%
AVXL - CRVO
27%
Poorly correlated
-2.43%
ONC - CRVO
27%
Poorly correlated
-0.73%
More